Ursula Matulonis

28PUBLICATIONS
247CO-AUTHORS
ChemotherapyOncology and carcinogenesis not elsewhere classifiedMolecular targetsPacific Peoples theory of change models for healthEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Mar 11, 2026
What does the future hold for antibody-drug conjugate therapies in ovarian cancer?

Page C Widick, Ursula A Matulonis, Meghan Shea

|Jul 23, 2025
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without <i>BRCA</i> Mutation.

Panagiotis A Konstantinopoulos, Jae Weon Kim, Gilles Freyer

|Apr 10, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.

Panagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee

|Mar 10, 2025
Usability, Acceptability, and Barriers to Implementation of a Collaborative Agenda-Setting Intervention (CASI) to Promote Person-Centered Ovarian Cancer Care: Development Study.

Rachel A Pozzar, James A Tulsky, Donna L Berry

|Feb 20, 2025
Smartphone-based measures as real-world indicators of functional status in advanced cancer patients.

Marcin Straczkiewicz, Nancy L Keating, Stephanie M Schonholz

|Feb 11, 2025
Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial Carcinoma.

Zelei Yang, Saie Mogre, Hyeji Jun

Pageof 5

Frequent Collaborators

7 joint publications

Panagiotis A Konstantinopoulos

6 joint publications

Domenica Lorusso

6 joint publications

Joyce F Liu

5 joint publications

Madeline Polak